1. Home
  2. RLJ vs ANNX Comparison

RLJ vs ANNX Comparison

Compare RLJ & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ

RLJ Lodging Trust of Beneficial Interest $0.01 par value

HOLD

Current Price

$8.39

Market Cap

1.1B

Sector

Real Estate

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.21

Market Cap

918.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLJ
ANNX
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
918.2M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
RLJ
ANNX
Price
$8.39
$5.21
Analyst Decision
Hold
Strong Buy
Analyst Count
7
6
Target Price
$8.75
$16.50
AVG Volume (30 Days)
1.6M
2.3M
Earning Date
02-26-2026
03-02-2026
Dividend Yield
7.23%
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$1,351,163,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.36
N/A
P/E Ratio
$188.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.16
$1.29
52 Week High
$9.85
$7.18

Technical Indicators

Market Signals
Indicator
RLJ
ANNX
Relative Strength Index (RSI) 68.99 39.79
Support Level $7.26 $5.46
Resistance Level $7.92 $5.79
Average True Range (ATR) 0.22 0.42
MACD 0.09 -0.19
Stochastic Oscillator 98.70 6.46

Price Performance

Historical Comparison
RLJ
ANNX

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: